Progestin therapy for endometrial cancer: The potential of fourth-generation progestin (Review)

Author： Banno Kouji Kisu Iori Yanokura Megumi Tsuji Kosuke Masuda Kenta Ueki Arisa Kobayashi Yusuke Yamagami Wataru Nomura Hiroyuki Susumu Nobuyuki Aoki Daisuke

Publisher： Spandidos Publications

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.40, Iss.6, 2012-06, pp. : 1755-1762

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Down-Regulation of Bcl-2 Is a Potential Marker of the Efficacy of Progestin Therapy in the Treatment of Endometrial Hyperplasia

By Amezcua C.A. Zheng W. Muderspach L.I. Felix J.C.

Gynecologic Oncology, Vol. 73, Iss. 1, 1999-04 ,pp. : 126-136

Elsevier

Access to resources Recommend Favorite

Apoptosis May Be an Early Event of Progestin Therapy for Endometrial Hyperplasia

By Amezcua C.A. Lu J.J. Felix J.C. Stanczyk F.Z. Zheng W.

Gynecologic Oncology, Vol. 79, Iss. 2, 2000-11 ,pp. : 169-176

Elsevier

Access to resources Recommend Favorite

Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States)

By Newcomb P.A.

Cancer Causes and Control, Vol. 14, Iss. 2, 2003-03 ,pp. : 195-201

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen and estrogen–progestin replacement therapy and risk of postmenopausal breast cancer in Canada

By Kirsh V.

Cancer Causes and Control, Vol. 13, Iss. 6, 2002-08 ,pp. : 583-590

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen–progestin replacement therapy and breast cancer risk: the Women's Health Study (United States)

By Porch J.V.

Cancer Causes and Control, Vol. 13, Iss. 9, 2002-11 ,pp. : 847-854

Springer Publishing Company

Access to resources Recommend Favorite